Amal Therapeutics
-
2012
Company Description
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal Therapeutics was incorporated in September 2012. Amal uses its proprietary cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Company Website:
-
Company E-mail:
-
Company Address:
64 av., de la RoseraieGenevaSwitzerland -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits